Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect. [electronic resource]
Producer: 20111027Description: 1682-1690 p. digitalISSN:- 1569-8041
- Adult
- Antineoplastic Agents -- therapeutic use
- Blotting, Western
- Cell Proliferation -- drug effects
- Female
- Flow Cytometry
- Fluorescent Antibody Technique
- Follow-Up Studies
- Humans
- Immunoenzyme Techniques
- Immunoprecipitation
- In Situ Hybridization, Fluorescence
- Indoles -- therapeutic use
- Male
- Middle Aged
- Proto-Oncogene Proteins c-ret -- genetics
- Pyrroles -- therapeutic use
- Receptor, Platelet-Derived Growth Factor beta -- antagonists & inhibitors
- Retrospective Studies
- Sarcoma, Alveolar Soft Part -- drug therapy
- Sunitinib
- Survival Rate
- Treatment Outcome
- Vascular Endothelial Growth Factor Receptor-2 -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.